Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-20,033
Closed -$2.99M 548
2021
Q3
$2.99M Buy
20,033
+16,031
+401% +$3.33M 0.21% 150
2021
Q2
$980K Buy
+4,002
New +$1.05M 0.12% 213
2020
Q4
Sell
-7,123
Closed -$1.68M 419
2020
Q3
$1.68M Buy
+7,123
New +$1.62M 0.37% 82

Other funds holding AMED

TwinBeech Capital's AMED Position: Q4 2021 in Review

TwinBeech Capital sold out of Amedisys (AMED) in Q4 2021, closing a stake of 20,033 shares — an estimated $2.99M sold.

TwinBeech Capital first reported a position in AMED in Q3 2020 and held it in 3 quarters. The position peaked at $2.99M in Q3 2021. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • TwinBeech Capital reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • TwinBeech Capital sold 20,033 Amedisys shares in Q4 2021, an estimated $2.99M.
  • TwinBeech Capital first reported a position in Amedisys in Q3 2020 and held it in 3 quarters.
  • TwinBeech Capital's Amedisys position peaked at $2.99M in Q3 2021.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on TwinBeech Capital's 13F filing for Q4 2021, filed 14 Feb 2022.